Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 678924, 12 pages
http://dx.doi.org/10.1155/2015/678924
Research Article

The Association between Serum LDL Cholesterol and Genetic Variation in Chromosomal Locus 1p13.3 among Coronary Artery Disease Patients

1Health Sciences Department, CAS, Qatar University, P.O. Box 2713, Doha, Qatar
2Cardiology Unit, Ahmed Maher Teaching Hospital, Cairo, Egypt
3Clinical Medicine, Weill Cornell Medical School, P.O. Box 24144, Doha, Qatar
4Cardiology Unit, Al-Emadi Hospital, P.O. Box 5804, Doha, Qatar
5Clinical Chemistry Department, Hamad Medical Corporation (HMC), P.O. Box 3050, Doha, Qatar
6Cardiology Department, Heart Hospital, Hamad Medical Corporation (HMC), P.O. Box 3050, Doha, Qatar

Received 16 July 2014; Revised 5 November 2014; Accepted 29 December 2014

Academic Editor: Kosmas Paraskevas

Copyright © 2015 Nasser M. Rizk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. US Institute of Medicine, “Epidemiology of cardiovascular disease,” in Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health, V. Fuster and B. B. Kelly, Eds., National Academic Press, Washington, DC, USA, 2010. View at Google Scholar
  2. C. J. Schwartz, A. J. Valente, and E. A. Sprague, “A modern view of atherogenesis,” The American Journal of Cardiology, vol. 71, no. 6, pp. 9B–14B, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Erqou, S. Kaptoge, P. L. Perry et al., “Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality,” Journal of the American Medical Association, vol. 302, no. 4, pp. 412–423, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Saghafi, M. J. Mahmoodi, H. Fakhrzadeh, R. Heshmat, A. Shafaee, and B. Larijani, “Cardiovascular risk factors in first-degree relatives of patients with premature coronary artery disease,” Acta Cardiologica, vol. 61, no. 6, pp. 607–613, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Yang, A. S. S. Mohamed, and S. H. Zhou, “Oxidized low density lipoprotein, stem cells, and atherosclerosis,” Lipids in Health and Disease, vol. 11, article 85, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. U. P. Steinbrecher, H. Zhang, and M. Lougheed, “Role of oxidatively modified LDL in atherosclerosis,” Free Radical Biology and Medicine, vol. 9, no. 2, pp. 155–168, 1990. View at Google Scholar · View at Scopus
  7. J. Vakkilainen, S. Mäkimattila, A. Seppälä-Lindroos et al., “Endothelial dysfunction in men with small LDL particles,” Circulation, vol. 102, no. 7, pp. 716–721, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Baigent, A. Keech, P. M. Kearney et al., “Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins,” The Lancet, vol. 366, no. 9493, pp. 1267–1278, 2005. View at Publisher · View at Google Scholar
  9. S. Padmanabhan, C. Hastie, D. Prabhakaran, and A. F. Dominczak, “Genomic approaches to coronary artery disease,” Indian Journal of Medical Research, vol. 132, no. 11, pp. 567–578, 2010. View at Google Scholar · View at Scopus
  10. N. J. Samani, J. Erdmann, A. S. Hall et al., “Genomewide association analysis of coronary artery disease,” The New England Journal of Medicine, vol. 357, no. 5, pp. 443–453, 2007. View at Google Scholar
  11. Y. S. Aulchenko, S. Ripatti, and I. Lindqvist, “Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts,” Nature Genetics, vol. 41, no. 1, pp. 47–55, 2009. View at Publisher · View at Google Scholar
  12. M. E. Kleber, W. Renner, T. B. Grammer et al., “Association of the single nucleotide polymorphism rs599839 in the vicinity of the sortilin 1 gene with LDL and triglyceride metabolism, coronary heart disease and myocardial infarction. The Ludwigshafen Risk and Cardiovascular Health Study,” Atherosclerosis, vol. 209, no. 2, pp. 492–497, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Kjolby, O. M. Andersen, T. Breiderhoff et al., “Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export,” Cell Metabolism, vol. 12, no. 3, pp. 213–223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. M. S. Sandhu, D. M. Waterworth, S. L. Debenham et al., “LDL-cholesterol concentrations: a genome-wide association study,” The Lancet, vol. 371, no. 9611, pp. 483–491, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Kathiresan, O. Melander, C. Guiducci et al., “Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans,” Nature Genetics, vol. 40, no. 2, pp. 189–197, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. C. J. Willer, S. Sanna, A. U. Jackson et al., “Newly identified loci that influence lipid concentrations and risk of coronary artery disease,” Nature Genetics, vol. 40, no. 2, pp. 161–169, 2008. View at Publisher · View at Google Scholar
  17. A. Muendlein, S. Geller-Rhomberg, C. H. Saely et al., “Significant impact of chromosomal locus 1p13.3 on serum LDL cholesterol and on angiographically characterized coronary atherosclerosis,” Atherosclerosis, vol. 206, no. 2, pp. 494–499, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Karvanen, K. Silander, F. Kee et al., “The impact of newly identified loci on coronary heart disease, stroke and total mortality in the MORGAM prospective cohorts,” Genetic Epidemiology, vol. 33, no. 3, pp. 237–246, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Wallace, S. J. Newhouse, P. Braund et al., “Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia,” The American Journal of Human Genetics, vol. 82, no. 1, pp. 139–149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. E. E. Schadt, C. Molony, E. Chudin et al., “Mapping the genetic architecture of gene expression in human liver,” PLoS Biology, vol. 6, no. 5, article e107, 2008. View at Publisher · View at Google Scholar
  21. E. Braunwald, E. M. Antman, J. W. Beasley, and et al, “ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina),” Circulation, vol. 102, no. 10, pp. 1193–1209, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 36, supplement 1, pp. S67–S74, 2012. View at Publisher · View at Google Scholar
  23. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), “Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report,” Circulation, vol. 106, no. 25, pp. 3143–3421, 2002. View at Google Scholar
  24. World Health Organization, “Obesity: preventing and managing the global epidemic. Report of a WHO Consultation,” World Health Organization Technical Report Series 894, 2000. View at Google Scholar
  25. P. J. Harris, V. S. Behar, M. J. Conley et al., “The prognostic significance of 50% coronary stenosis in medically treated patients with coronary artery disease,” Circulation, vol. 62, no. 2, pp. 240–248, 1980. View at Publisher · View at Google Scholar · View at Scopus
  26. N. M. Rizk, A. El-Menyar, I. Marei et al., “Association of adiponectin gene polymorphism (+T45G) with acute coronary syndrome and circulating adiponectin levels,” Angiology, vol. 64, no. 4, pp. 257–265, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Linsel-Nitschke, A. Götz, J. Erdmann et al., “Lifelong reduction of LDL-cholesterol related to a common varriant in the LDL-receptor gene decreases the risk of coronary artery disease—a Mendelian randomisation study,” PLoS ONE, vol. 3, no. 8, Article ID e2986, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Foraita, “A conditional synergy index to assess biological interaction,” European Journal of Epidemiology, vol. 24, no. 9, pp. 485–494, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Gigante, A. M. Bennet, K. Leander, M. Vikström, and U. de Faire, “The interaction between coagulation factor 2 receptor and interleukin 6 haplotypes increases the risk of myocardial infarction in men,” PLoS ONE, vol. 5, no. 6, Article ID e11300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. K. J. Rothman, “The estimation of synergy or antagonism,” American Journal of Epidemiology, vol. 103, no. 5, pp. 506–511, 1976. View at Google Scholar · View at Scopus
  31. M. Lundberg, P. Fredlund, J. Hallqvist, and F. Diderichsen, “A SAS program calculating three measures of interaction with confidence intervals,” Epidemiology, vol. 7, no. 6, pp. 655–656, 1996. View at Google Scholar · View at Scopus
  32. B. Gigante, K. Leander, M. Vikström, S. Ye, and U. de Faire, “Chromosome 1p13 genetic variants antagonize the risk of myocardial infarction associated with high ApoB serum levels,” BMC Cardiovascular Disorders, vol. 12, article 90, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. N. J. Samani, P. S. Braund, J. Erdmann et al., “The novel genetic variant predisposing to coronary artery disease in the region of the PSRC1 and CELSR2 genes on chromosome 1 associates with serum cholesterol,” Journal of Molecular Medicine, vol. 86, no. 11, pp. 1233–1241, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. N. M. Roslin, J. S. Hamid, A. D. Paterson, and J. Beyene, “Genome-wide association analysis of cardiovascular-related quantitative traits in the Framingham Heart Study,” BMC Proceedings, vol. 3, supplement 7, p. S117, 2009. View at Publisher · View at Google Scholar
  35. L. Zhou, H. Ding, X. Zhang et al., “Genetic variants at newly identified lipid loci are associated with coronary heart disease in a Chinese Han population,” PLoS ONE, vol. 6, no. 11, Article ID e27481, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Linsel-Nitschke, J. Heeren, Z. Aherrahrou et al., “Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease,” Atherosclerosis, vol. 208, no. 1, pp. 183–189, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Musunuru, A. Strong, M. Frank-Kamenetsky et al., “From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus,” Nature, vol. 466, no. 7307, pp. 714–719, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Angelakopoulou, T. Shah, R. Sofat et al., “Comparative analysis of genome-wide association studies signals for lipids, diabetes, and coronary heart disease: Cardiovascular Biomarker Genetics Collaboration,” European Heart Journal, vol. 33, no. 3, pp. 393–407, 2012. View at Publisher · View at Google Scholar · View at Scopus